Skip to content
Riskpilot
← Tilbage til søgning
Log ind
Få fuld adgang
MICROPHIX AS
AS
Active
Org 934981448
Hans Nielsen Hauges gate 42, 0481
Oslo
Research and experimental development on natural sciences and engineering
·
NACE 7210
Est. 2025 · 1 year old
— employees
Overvåg
Share
Norway
/
Companies
/
Research and experimental development on natural sciences and engineering
/
MICROPHIX AS
Overview
Financials
People & ownership
Related companies
Loading company…
Financials
Revenue
NOK millions
0M
0M
1M
1M
1M
0M
2025
EBITDA
NOK millions
0M
-0M
-1M
-1M
-1M
0M
2025
Income statement
NOK thousands
Item
2025
Revenue
0
Staff expenses
−0
EBITDA
−26
Depreciation & amort.
−0
EBIT
−26
Net financials
0
Profit before tax
−26
Tax
−6
Net profit
−20
Balance sheet
NOK thousands
Item
2025
Total assets
100
Equity
100
Long-term debt
0
Short-term debt
0
Total debt
0
Financial ratios
5-year trend
EBITDA-margin
-2619600.0%
This company
15.8%
Market median
-16579847% vs market
2025
2025
Soliditetsgrad
100.0%
This company
38.2%
Market median
+162% vs market
2025
2025
Egenkapitalforrentning
-20.2%
This company
18.4%
Market median
-210% vs market
2025
2025
Nettoresultatgrad
-2021100.0%
This company
8.1%
Market median
-24951952% vs market
2025
2025
Aktivomsætning
0.00×
This company
1.12×
Market median
-100% vs market
2025
2025
Gæld/egenkapital
0.00×
This company
0.62×
Market median
+100% vs market
2025
2025
Annual reports & filings
Annual report 2025
Filed via Brønnøysundsregistrene · Period 2025-01-24 – 2025-12-31
View
PDF
More on MICROPHIX AS
Overview →
Headline figures, risk assessment and company summary
People & ownership →
Management, board and shareholder breakdown
Related companies →
Corporate hierarchy, parent and subsidiary network
